These were the biggest pharmaceutical deals in early 2022
GlobalData tracks the latest acquisitions, mergers, venture financing and asset transactions in the pharmaceutical sector.
By
GlobalData tracks the latest acquisitions, mergers, venture financing and asset transactions in the pharmaceutical sector.
ByThe data shows that M&A activity is strongest in the US, which saw a total of 19 deals announced in…
ByThe tobacco company’s buyout of a healthcare business has sparked both fury and confusion from campaigners and politicians.
ByThree companies have merged to form the UK’s first nationwide life sciences ecosystem, boosting R&D and drug discovery capacity in…
ByAstraZeneca’s proposed $39bn acquisition of rare disease therapy company Alexion Pharmaceuticals has passed a US Federal Trade Commission review.
ByExscientia has raised $100m in its second Series C in the past nine months. The round was led by BlackRock,…
BySIRION and Sanofi are partnering to develop improved AAV vectors to overcome some of the challenges facing gene therapies. The…
ByMerck has acquired Pandion Therapeutics for $1.85bn. The deal centres around Pandion’s TALON technology and immune modulators, which re-balance the…
ByThank you for subscribing to Pharmaceutical Technology